Drug Patent Watch
DECEMBER 29, 2020
This chart shows the pharmaceutical companies with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Marketing Network
DECEMBER 29, 2020
2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. The COVID-19 pandemic pushed the industry to experiment with new media, emerging technologies and innovative platforms to keep physicians, providers and patients informed, engaged and empowered. As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connec
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NY Times
DECEMBER 28, 2020
Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.
pharmaphorum
DECEMBER 31, 2020
The post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some degree of stability – but also plenty of disruption – for the coming months and years. The UK is leaving the EU’s single market and customs union, but the deal means tariffs on goods won’t be imposed when the transition period ends at 23:00 GMT tonight.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Drug Patent Watch
DECEMBER 30, 2020
Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eight patents protecting this drug. INVELTYS drug…. The post New patent for Kala Pharms drug INVELTYS appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
DECEMBER 30, 2020
We should expect some people to experience side effects. The shot is still safer than the disease.
Med Ed 101
DECEMBER 30, 2020
It is well known that we create study materials for several board exams. I’m often one of the first to know when changes happen because people ask me how it should impact their preparations! The 2021 BCMTMS Exam changes are some of the most expansive that I have seen to any board exam. You must […]. The post 2021 BCMTMS Exam Changes and Why It Will Be Harder appeared first on Med Ed 101.
Drug Patent Watch
JANUARY 1, 2021
This chart shows the pharmaceutical companies with the most patents in Israel. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Israel? appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacy Joe
DECEMBER 27, 2020
In this episode, I’ll discuss the evidence for gastrointestinal cation exchangers other than sodium polystyrene sulfate in acute hyperkalemia. Episode 569: Evidence for gastrointestinal cation exchangers other than sodium polystyrene sulfate in acute hyperkalemia Subscribe on iTunes , Android , or Stitcher In the treatment of acute hyperkalemia, IV calcium provides immediate cardioprotection and allows time for insulin to move potassium into the intracellular space and away from the heart.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
NY Times
DECEMBER 28, 2020
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That’s not wise, health experts say.
Med Ed 101
DECEMBER 27, 2020
While I primarily practice in geriatrics, I’ve also spent some time in community pharmacy and of course, get asked questions about medications in kids from time to time. In addition to getting asked questions in clinical practice, you’ll likely be tested on some of these pearls when taking board exams and pharmacology classes. Here are […].
Drug Patent Watch
DECEMBER 31, 2020
This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 30, 2020
The UK has approved AstraZeneca and Oxford University’s COVID-19 vaccine AZD1222 in another significant step forward in the fight against the pandemic, with first doses due to be administered on Monday. The UK government has already ordered 100 million doses of the adenovirus-based shot, enough to vaccinate 50 million people, adding to the 40 million dose order of the Pfizer/BioNTech shot – now known as Comirnaty – that was approved earlier this month.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
NY Times
DECEMBER 28, 2020
Doctors often prescribe them for sore throats and the common cold, even though evidence of benefit is sorely lacking.
Drug Patent Watch
DECEMBER 30, 2020
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Estonia. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Estonia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 30, 2020
Annual Drug Patent Expirations for EYSUVIS Eysuvis is a drug marketed by Kala Pharms Inc and is included in one NDA. The generic ingredient in EYSUVIS is loteprednol etabonate. Additional…. The post New patent for Kala Pharms drug EYSUVIS appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 28, 2020
This chart shows the pharmaceutical companies with the most gel dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gel dosed drugs…. The post Which pharmaceutical companies have the most gel dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
DECEMBER 28, 2020
Annual Drug Patent Expirations for EPHEDRINE+SULFATE Ephedrine Sulfate is a drug marketed by Akorn, Amneal, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Nevakar, and Sandoz Inc and, and is included…. The post New patent for Nevakar drug EPHEDRINE SULFATE appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 27, 2020
This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 27, 2020
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one NDA. It is available from one supplier. There are five…. The post New patent expiration for Bristol Myers drug SPRYCEL appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
DECEMBER 26, 2020
This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Denmark? appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Patent Watch
DECEMBER 29, 2020
SPRYCEL (dasatinib) Bristol myers squibb Patent: 6,596,746 Expiration: Dec 28, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…. The post Drug Patent Expirations for the Week of December 27, 2020 appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
DECEMBER 29, 2020
NHS England’s chief executive Sir Simon Stevens has said that all vulnerable people over the age of 50 will be offered a COVID-19 vaccine by “late spring” in a message to healthcare workers. The prediction comes after the NHS announced on Christmas Eve that more than half a million people had received the Pfizer/BioNTech shot approved in early December, but will depend on additional vaccine supplies coming “on stream”, according to Stevens.
Expert insights. Personalized for you.
98 
Let's personalize your content